Dual pharmacological targeting of hdacs and pde5 inhibits liver disease progression in a mouse model of biliary inflammation and fibrosis

1. Claveria-Cabello, A.
2. Colyn, L.
3. Uriarte, I.
4. Ujue Latasa, M.
5. Arechederra, M.
6. Herranz, J.M.
7. Alvarez, L.
8. Urman, J.M.
9. Martinez-Chantar, M.L.
10. Banales, J.M.
11. Sangro, B.
12. Rombouts, K.
13. Oyarzabal, J.
14. Marin, J.J.G.
15. Berasain, C.
16. Avila, M.A.
17. Fernandez-Barrena, M.G.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3390/CANCERS12123748 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

•